期刊文献+

骨碎补总黄酮对去卵巢大鼠RANKL/OPG平衡及MAPK信号通路的影响 被引量:9

Effects of drynaria total flavonoids on RANKL/OPG balance and MAPK signaling pathways in overiectomized rats
下载PDF
导出
摘要 目的观察骨碎补总黄酮对去卵巢大鼠核因子κB受体活化因子配体(RANKL)/骨保护素(OPG)表达及丝裂原活化蛋白激酶(MAPK)信号通路的影响。方法选用雌性大鼠45只,分为假手术组(15只)和手术组(30只),手术组行双侧卵巢切除术,造模12周时测定BMD,确认OP复制成功后,将手术组大鼠又随机分为模型组和骨碎补总黄酮给药组,每组均15只;给药组大鼠给予骨碎补总黄酮灌胃,持续时间为12周,模型组和假手术组同时给予等量生理盐水灌胃;实验结束后测定大鼠的BMD,ELISA法检测大鼠血清RANKL、OPG含量,RT-PCR检测大鼠骨组织RANKL、OPG m RNA表达,Western blot法检测骨组织c-Jun氨基末端激酶(JNK)、p38MAPK(p38)、细胞外调节激酶(ERK)的磷酸化水平及c-Fos表达。结果干预治疗12周后:(1)与假手术组相比,模型组大鼠左、右股骨BMD降低(P<0.05),血清RANKL含量增加、OPG含量降低、RANKL-OPG比值增大(P均<0.05),骨组织RANKL m RNA表达增加、OPGm RNA表达减少(P均<0.05)。(2)与模型组比较,假手术组和骨碎补总黄酮治疗组左、右股骨BMD均增加(P均<0.05),血清RANKL含量降低、OPG含量增加、RANKL-OPG比值减小(P均<0.05),骨组织RANKL m RNA表达减少、OPG m RNA表达增加(P均<0.05),且假手术组和骨碎补总黄酮治疗组之间比较差异有统计学意义(P<0.05);(3)与模型组比较,假手术组和骨碎补总黄酮治疗组大鼠骨组织P-JNK、c-Fos表达降低(P均<0.05),但这两组间比较差异无统计学意义(P>0.05)。结论骨碎补总黄酮可增加去卵巢大鼠骨密度,其途径可能是通过调节RANKL-OPG平衡、抑制JNK磷酸化及c-Fos表达实现的。 Objective To explore the effect ofdrynaria total flavonoids on receptor activator of nuclear fac- tor kappa B ligand (RANKL)/Osteoprotegerin (OPG) expression and mitogen-activated protein kinase (MAPK) signal- ing pathways in ovariectomized rats. Methods Forty-five female rats were divided into sham operation group (15 rats) and operation group (30 rats). The rats in operation group all underwent ovariectomy and had bone mineral densi- ty (BMD) detected 12 weeks later. After confirming the success of OP, the rats in operation group were divided into drynaria total fiavonoids group and model group, with 15 rats in each group. The drynaria total fiavonoids group was treated with drynaria total fiavonoids solution, while the model group and sham operation group received gastric perfu- sion of normal saline. The duration of treatment was 12 weeks. The level of BMD was checked. The expression of RANKL, OPG was detected by ELISA. The expression of RANKL and OPG mRNA of femur was detected by RT-PCR. Western blotting analysis was used to examine the phosphorylation of c-Jun Ntermingal kinase (JNK), MAPK p38, extracellular-regulated kinase ERK, and c-FOS protei expression in bone tissues. Results (1) Compared with sham operation group, after 12-week treatment, the BMD in model group were significantly lower (P〈0.05). The serum RANKL level increased significantly, serum OPG level decreased significantly, and the RANKL/OPG ratio in- creased significantly (all P〈0.05). The RANKL mRNA expression significantly increased and OPG mRNA decreased significantly in bone tissues (all P〈0.05). (2) Compared with model group, BMD was higher than that of rats in sham operation group and drynaria total flavonoids group (all P〈0.05). The serum RANKL level decreased significantly, and the serum OPG level increased significantly, with the RANKL/OPG ratio decreased significantly (all P〈0.05). The RANKL mRNA expression decreased significantly and OPG mRNA increased significantly in bone tissues (all P〈 0.05). There were significant differences among sham operation group and drynaria total flavonoids group (P〈0.05). (3) Compared with model group, bone tissue P-JNK and c-Fos expression in rats in sham operation group and drynaria total flavonoids group wcrc lower, but there were no significant differences among sham operation group and drynaria total flavonoids group (P〉0.05). Conclusion Drynaria total flavonoids group can improve the BMD values in ovari- ectomizcd rats, which may be related to its function in regulating the balance of RANKL/OPG and inhibiting the expression of JNK phosphorylation and c-Fos.
出处 《海南医学》 CAS 2015年第9期1249-1253,共5页 Hainan Medical Journal
基金 海南省自然科学基金(编号:811156) 海南省卫生厅资助项目(编号:琼卫2010-69)
关键词 骨碎补总黄酮 骨质疏松 MAPK信号通路 Drynaria total flavonoids Osteoporosis MAPK signaling pathways
  • 相关文献

参考文献12

  • 1潘正论,许菁,李凤,陈立辉,张源潮.骨质疏松症的相关信号转导通路研究[J].世界临床药物,2012,33(2):112-115. 被引量:3
  • 2赛顺华.补肾化痰方对骨质疏松大鼠成骨作用影响的实验研究[D].武汉:湖北中医药大学,2011.
  • 3Devlin H, Ferguson MW. Compositional changes in rat femur fol- lowing ovariectomy [J]. Acta Auatomica, 1989, 136(1): 38-41.
  • 4Kalu DN, Hardin RP,, Cockerham R. Evaluation of the pathogenesis of skeletal changes in ovaricctomised rats [J]. Endocrinology, 1984, 115(2): 507-512.
  • 5Yin JL, Shackel NA, Zekry A, et al. Real-time reverse-transcriptase polymerase chain reaction (RT-PCT) for measurement of cytokine and growth factor mRNA expression uwith fluorogenic probes or SYBR Green I [J]. Immtmol Cell Biol, 2001, 79(3): 213-221.
  • 6Coctzee M, Kruger MC. Osteoprotegerin-receptor activator of nucle- ar factor-kappaB ligand ratio: a new approach to ostcoporosis treat- ment [J]. South Med J, 2004, 97(5): 506-511.
  • 7Hodge JM, Collier FM, Pavlos NJ, et al. M-CSF potently augments RANKL induced resorption activation in mature human osteoporo- sis [J]. PloS One, 2011, 6: e21462.
  • 8Schoppet M, Preissner KT, Hofbauer LC. RANKL ligand and osteo- protegerin: paracrine regulators of bonemetabolism and vascular funcation [J]. Arterioscler Thromb Vasc Biol, 2002, 22(4): 549-553.
  • 9Hofbauer LC, Khosla S, Dunstan CR, et al. The roles of osteoprote- gerin and osteoprotegerin ligand in the paracrine regulators of bone resorption [J]. J Bone Miner Res, 2000, 15(1): 2-12.
  • 10Halleen JM, Alatalo SL, Janckila A J, et al. Serum tartarate resistant- acid pbosphatase 5b is a specific and sensitive rnsrker of bone re- sorption [J]. Clin Chem, 2001, 47(3): 597-600.

二级参考文献29

共引文献30

同被引文献201

引证文献9

二级引证文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部